Edwin Wagena
Amministratore Delegato presso Sutura Therapeutics Ltd.
Provenienza dei contatti di primo grado di Edwin Wagena
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Edwin Wagena tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
VERNALIS | Pharmaceuticals: Major | Director of Finance/CFO | |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Director/Board Member | |
Anthra Pharmaceuticals, Inc.
Anthra Pharmaceuticals, Inc. Medical DistributorsDistribution Services Anthra Pharmaceuticals, Inc. is an American company. | Medical Distributors | Director/Board Member | |
STRATA SKIN SCIENCES, INC. | Medical Specialties | Director/Board Member | |
HELIAD EQUITY PARTNERS GMBH & CO. KGAA | Investment Managers | Chief Executive Officer | |
Axellis, Inc.
Axellis, Inc. Medical DistributorsDistribution Services Axellis, Inc. sells and distributes medical devices. Its products are used for oncology and cardiology. The company was founded in August 2007 and is headquartered in London, UK | Medical Distributors | Director/Board Member | |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member | |
GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
ADVANCED MEDICAL SOLUTIONS GROUP PLC | Medical Specialties | Director/Board Member | |
University of Oxford | College/University | Graduate Degree | |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Commerzbank Finance Ltd.
Commerzbank Finance Ltd. Investment Banks/BrokersFinance Part of Commerzbank AG, Commerzbank Finance Ltd. is a British company that provides securities brokerage services. The company is based in London, UK. Commerzbank Finance was founded in 1955. | Investment Banks/Brokers | Director/Board Member | |
OREXO AB | Pharmaceuticals: Major | Chairman | |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Universität zu Köln | College/University | Doctorate Degree | |
Heliad Management GmbH
Heliad Management GmbH Investment ManagersFinance Heliad Management GmbH (Heliad) is the wholly-owned private equity subsidiary of FinLab AG (FR: A7A). Formerly known as Sigma Capital Management GmbH, the firm was established in 2000 as VertureCap Consultants GmbH. It was renamed to Sigma Capital in 2006 and subsequently became Altira Heliad Management GmbH. Since 2016 the firm is known as Heliad Management GmbH. The firm is headquartered in Frankfurt, Germany. | Investment Managers | Chief Executive Officer | |
HELIAD AG | Investment Managers | Corporate Officer/Principal | |
Oxfordshire Biotechnet Ltd.
Oxfordshire Biotechnet Ltd. Investment ManagersFinance Oxfordshire Biotechnet Ltd. is a venture capital fund. | Investment Managers | Director/Board Member | |
Adprotech Pharmaceuticals, Inc. | Director/Board Member | ||
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Founder | |
Teva Pharmaceuticals Ltd.
Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Julius-Maximilians-Universität Würzburg | College/University | Masters Business Admin | |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Chairman | |
Springlane GmbH
Springlane GmbH Catalog/Specialty DistributionRetail Trade Springlane GmbH develops and operates an online food and kitchenware shopping portal. It provides users with a web-based platform for searching and buying cooking equipment and kitchen accessories, such as cooking pots and pans, electronic grills, rice cookers, glassware, plates and cups, utensils, and table decoration. It also offers a selection of wine and gourmet food products. The company was founded by Lars Christian Wilde, Marius Till Fritzsche, Alexander Luik, Nils Wilde, and Björn Rust in 2012 and is headquartered in Dusseldorf, Germany. | Catalog/Specialty Distribution | Chairman | |
Alphapet Ventures GmbH
Alphapet Ventures GmbH Specialty StoresRetail Trade Alphapet Ventures GmbH engages in the operation of e-commerce platforms for the sale of pet food and other related services. its strategy is based on the digitization of the pet nutrition market combined with brand building and multi-channel distribution facilities. The company was founded in 2016 and is headquartered in Munich, Germany. | Specialty Stores | Consultant / Advisor | |
Neodigital Versicherung AG
Neodigital Versicherung AG Life/Health InsuranceFinance Neodigital Versicherung AG is a holding company, which provides online insurance solutions. It offers accident insurance, home insurance, personal liability insurance, as well as pet owner liability insurance. The company was founded by Dirk Wittling and Stephen Voss on December 27, 2016 and is headquartered in Neunkirchen, Germany. | Life/Health Insurance | Director/Board Member | |
Pneumagen Ltd.
Pneumagen Ltd. BiotechnologyHealth Technology Pneumagen Ltd. is engaged in biotechnology services. The company was founded in 2016 and is headquartered in Fife, the United Kingdom. | Biotechnology | Chairman | |
MYNARIC AG | Telecommunications Equipment | Director/Board Member | |
029 GROUP SE | Information Technology Services | Director/Board Member | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
SYNBIOTIC SE | Miscellaneous Commercial Services | Director/Board Member | |
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Consultant / Advisor | |
Kleinwort Benson Ltd. (New York) | Director/Board Member | ||
Elevat3 Capital Ltd.
Elevat3 Capital Ltd. Investment ManagersFinance Elevat3 Capital Ltd (Elevat3) is a venture capital firm, a subsidiary of Apeiron Investment Group Ltd. founded in 2020 by Christian Angermayer, Marlon Braumann and Thomas Hanke. The firm is headquartered in London, United Kingdom. | Investment Managers | Founder | |
Ames Foundation | Investment Trusts/Mutual Funds | Founder | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Founder | |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue. | Hospital/Nursing Management | Chairman | |
Pneumagen (Holdings) Ltd. | Director/Board Member | ||
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Founder |
Statistiche
Distribuzione geografica
Regno Unito | 29 |
Germania | 13 |
Stati Uniti | 7 |
Svezia | 2 |
Paesi Bassi | 2 |
Settori
Health Technology | 20 |
Finance | 12 |
Miscellaneous | 4 |
Consumer Services | 4 |
Commercial Services | 4 |
Posizioni
Director/Board Member | 39 |
Chairman | 9 |
Chief Executive Officer | 6 |
Corporate Officer/Principal | 6 |
Independent Dir/Board Member | 6 |
Contatti più connessi
Insiders | |
---|---|
James Noble | 39 |
Thomas Hanke | 14 |
Volker Knappertz | 5 |
- Borsa valori
- Insiders
- Edwin Wagena
- Connessioni Società